Transdermal Delivery of Cosmetic Ingredients Using Dissolving Polymer Microneedle Arrays.
Park, Y., et al.
Biotechnology and Bioprocess Engineering, 2015
52
Robust Parameter Estimation for Physiologically Based Pharmacokinetic Model of Tegafur with Dissolution Dynamics.
Kim, D.S., J.H. Sung, J.M. Lee
Chemical Engineering Research and Design, 2015
53
A microfluidic cell culture device (muFCCD) to culture epithelial cells with physiological and morphological properties that mimic those of the human intestine.
Chi, M., et al.
Biomed Microdevices, 2015
54
Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure.
Sung, J.H., et al.
Exp Biol Med (Maywood), 2014
55
A microfluidic device for evaluating the dynamics of the metabolism-dependent antioxidant activity of nutrients.
Lee, J., et al.
Lab Chip, 2014
56
Three-dimensional intestinal villi epithelium enhances protection of human intestinal cells from bacterial infection by inducing mucin expression.
Kim, S.H., et al.
Integr Biol (Camb), 2014
57
Fabrication of DNA-Coated Microneedles for Transdermal DNA Delivery Science of Advanced Materials.
H., N., et al.
Science of Advanced Materials, 2014
58
Self-assembled DNA-based giant thrombin nanoparticles for controlled release.
Sung, J.H., D. Han, J.B. Lee
Biotechnol J, 2013
59
Microfabricated mammalian organ systems and their integration into models of whole animals and humans.
Sung, J.H., et al.
Lab Chip, 2013
60
Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.